BEN-101
/ Bennu Biotherap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 21, 2024
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=16 | Recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Not yet recruiting ➔ Recruiting | Trial completion date: Jun 2026 ➔ Jun 2027 | Trial primary completion date: Feb 2026 ➔ Feb 2027
Enrollment open • Metastases • Trial completion date • Trial primary completion date • Oncology • Solid Tumor
April 26, 2023
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=16 | Not yet recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1